NCT02246608View on ClinicalTrials.gov

Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

January 31, 2018

Conditions
Open Wound Abdominal WallWound Non Healing
Interventions
DEVICE

NPWT Standard of Care plus Oasis wound product

Oasis® is a porcine acellular small intestine submucosa material compatible with human tissue. It is a complex scaffold that provides optimal environment for restoration of tissue structure. It guides tissue growth and traps growth factors. Oasis Matrix indications include partial and full thickness wounds and skin loss injuries as well as second-degree burns.

DEVICE

Routine NPWT Standard of Care

Specialized material, often foam, designed to protect the wound and promote healing during NPWT.

Trial Locations (1)

45429

Kettering Medical Center, Kettering

All Listed Sponsors
lead

Kettering Health Network

OTHER

NCT02246608 - Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy | Biotech Hunter | Biotech Hunter